Length-dependent CTG·CAG triplet-repeat expansion in myotonic dystrophy patient-derived induced pluripotent stem

Jintang Du1, Erica Campau, Elisabetta Soragni

  • 1Department of Cell and Molecular Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA.

Human Molecular Genetics
|August 13, 2013
PubMed

Insights

Myotonic dystrophy type 1 (DM1) triplet repeat instability in induced pluripotent stem cells (iPSCs) was investigated. Longer repeats showed faster expansion, particularly between 57 and 126 repeats, with mismatch repair proteins like MSH2 playing a key role.

Area of Science:

  • Genetics
  • Molecular Biology
  • Stem Cell Biology

Background:

  • Myotonic dystrophy type 1 (DM1) is an inherited disorder caused by expanded CTG·CAG triplet repeats in the DMPK1 gene.
  • Disease severity correlates with repeat length, but the instability mechanism remains unclear.

Purpose of the Study:

  • To investigate the mechanism of CTG·CAG triplet-repeat instability in induced pluripotent stem cells (iPSCs) derived from DM1 patients.
  • To identify factors influencing repeat expansion and its cessation upon differentiation.

Main Methods:

  • Generation of iPSCs from DM1 patient fibroblasts.
  • Analysis of CTG·CAG repeat length instability during iPSC propagation and differentiation.
  • Assessment of mismatch repair (MMR) protein expression and function (MSH2, MSH3, MSH6).
  • Silencing of MSH2 using shRNA to evaluate its impact on repeat expansion.

Main Results:

  • DM1 iPSCs exhibited somatic instability with varying CTG·CAG repeat lengths.
  • Repeat expansion rates increased significantly between 57 and 126 repeats, with longer repeats expanding faster.
  • Triplet-repeat expansion ceased upon differentiation into embryoid bodies or neurospheres.
  • MSH2, MSH3, and MSH6 were highly expressed in iPSCs and localized to the DMPK1 gene.
  • MSH2 silencing inhibited CTG·CAG triplet-repeat expansion.

Conclusions:

  • iPSCs reveal a mechanism for CTG·CAG triplet-repeat expansion, influenced by repeat length and MMR proteins.
  • The findings provide new insights into triplet-repeat instability in iPSCs and its potential role in DM1 pathogenesis.

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...